SPY408.32+8.23 2.06%
DIA327.10+4.32 1.34%
IXIC11,984.52+321.73 2.76%

BRIEF-Bristol-Myers Squibb Reports QTRLY Revenues Of $11.6 Billion

reuters.com · 04/29/2022 06:59
BRIEF-Bristol-Myers Squibb Reports QTRLY Revenues Of $11.6 Billion

-

  • BRISTOL-MYERS SQUIBB - QTRLY REVENUES OF $11.6 BILLION, AN INCREASE OF 5% YOY; OR 7% WHEN ADJUSTED FOR FOREIGN EXCHANGE

  • BRISTOL-MYERS SQUIBB - QTRLY EARNINGS PER SHARE OF $0.59 AND QTRLY NON-GAAP EPS OF $1.96

  • BRISTOL-MYERS SQUIBB - ACQUIRED IPRD INCREASED TO $333 MILLION IN QUARTER, DUE TO UP-FRONT & MILESTONE CHARGES RELATING TO CERTAIN LICENSING ARRANGEMENTS

  • BRISTOL-MYERS SQUIBB - QTRLY OPDIVO REVENUE $1.92 BILLION VERSUS $1.72 BILLION

  • BRISTOL-MYERS SQUIBB - QTRLY ELIQUIS REVENUE $3.21 BILLION VERSUS $2.89 BILLION

  • BRISTOL-MYERS SQUIBB - QTRLY RESULTS INCLUDE NET NEGATIVE IMPACT OF $0.10/SHARE FOR GAAP & NON-GAAP EPS DUE TO ACQUIRED IPRDCHARGES

  • BRISTOL-MYERS SQUIBB - QTRLY REVLIMID REVENUE $2.80 BILLION VERSUS $2.94 BILLION

  • BRISTOL-MYERS SQUIBB - SEES FY TOTAL NET SALES IN-LINE WITH 2021 ON GAAP AND NON-GAAP BASIS

  • BRISTOL-MYERS SQUIBB - SEES FY REVLIMID REVENUES $9.0 BILLION - $9.5 BILLION ON GAAP AND NON-GAAP BASIS

  • BRISTOL-MYERS SQUIBB - SEES $10 BILLION DECLINE OR DOUBLE-DIGIT DECLINE IN RECENT LOE PRODUCTS FOR FY

  • BRISTOL-MYERS SQUIBB - SEES FY GAAP DILUTED EPS $2.92-$3.22 ; SEES FY NON-GAAP DILUTED EPS $7.44 - $.7.74

  • BRISTOL-MYERS SQUIBB - SEES LOW SINGLE-DIGIT DECLINE IN FY OPERATING EXPENSES

  • BRISTOL-MYERS SQUIBB - FY GUIDANCE FOR TOTAL NET SALES, REVLIMID & RECENT LOE SALES, BEING ADJUSTED DUE TO FOREIGN EXCHANGE

  • BRISTOL-MYERS - FY GUIDANCE FOR TOTAL NET SALES, REVLIMID & RECENT LOE SALES BEING ADJUSTED DUE TO FASTER EROSION OF REVLIMID IN INTERNATIONAL MARKETS

  • BRISTOL-MYERS - FY EARNINGS PER SHARE, ADJUSTED. EARNINGS PER SHARE OUTLOOK INCLUDES NEGATIVE IMPACT OF $0.11 DUE TO BUYOUT OF FUTURE ROYALTY OBLIGATION RELATED TO MAVACAMTEN

Source text for Eikon: [ID:]

Further company coverage: [ ]


((Reuters.Briefs@thomsonreuters.com;;))